Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
2.440
+0.150 (6.55%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Radiopharm Theranostics Stock Forecast
RADX's stock price has decreased by -63.42% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, Radiopharm Theranostics stock has a consensus rating of "Strong Buy" and an average price target of $17.36. The average 1-year stock price forecast is 611.48% higher than the current stock price, while the lowest is $12.72 (+421.31%) and the highest is $30.68 (+1,157.38%).
Price Target: $17.36 (+611.48%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 4, 2026.
Analyst Ratings
The average analyst rating for Radiopharm Theranostics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $16 | Buy | Initiates | $16 | +555.74% | Jun 4, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $15 | Buy | Maintains | $15 | +514.75% | Mar 26, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $30 | Buy | Reiterates | $30 | +1,129.51% | Mar 25, 2026 |
Financial Forecast
Revenue This Year
5.23M
from 12.51M
Decreased by -58.21%
Revenue Next Year
5.61M
from 5.23M
Increased by 7.33%
EPS This Year
-0.04
from -0.06
EPS Next Year
-0.06
from -0.04
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.